IRCT20210216050377N1已完成3 期
Evaluation of the therapeutic effect of Silymarin in combination with naloxone in improving methadone poisoning
Shahre-kord University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with opioid triad include decreased level of consciousness, myotic pupil and decreased level of blood oxygen
- •Methadone level is positive in their urine test (U / A)
排除标准
- •Patient dissatisfaction to participate in the study
- •Use of supplements and drugs with similar effects or interventions with Naloxone and Silymarin
研究者
相似试验
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
尚未招募
3 期
Evaluating the effectiveness of silymarin in preventing vancomycin nephrotoxicityVancomycin-induced nephrotoxicity in hospitalized patients.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditionsIRCT20161010030246N6Shiraz University of Medical Sciences80